Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Phase I trial of Herzyme commences in breast and ovarian cancer

Sep. 3, 2001

More information on the beneficial effects of resveratrol

Aug. 31, 2001

Research at Nippon Shinyaku leads to new antitumor compounds

Aug. 30, 2001

Meiji Seika discloses new antineoplastics isolated from fungus

Aug. 30, 2001

Exisulind reduces adenomatous colon polyps in clinical trial

Aug. 30, 2001

Virax to develop prostate cancer immunotherapy

Aug. 30, 2001

OSI Pharmaceuticals updates Tarceva development

Aug. 30, 2001

Natural antibacterial and antitumor agent isolated by Kyowa Hakko

Aug. 29, 2001

Novartis files FDA application for Zometa as treatment for bone metastases

Aug. 29, 2001

Phase II trial of MG-98 in renal cell carcinoma begins

Aug. 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...